Tanveer Ahmad, MD
Cardiology · Brick, NJNPI 1962464495
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 180 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $749 and has fallen 51.9% since, to $360 in 2025.
Across 180 payments — averaging $16.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$686
- Abbott$589
- Pfizer$309
- Novartis$193
- Biotronik Inc.$147
- Boston Scientific$140
- plus $929 from 19 others
What the payments were for
- Food & beverage$2,86096%
- Education$1334%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 52 | $686 |
| Abbott | 26 | $589 |
| Pfizer | 21 | $309 |
| Novartis | 13 | $193 |
| Biotronik Inc. | 5 | $147 |
| Boston Scientific | 9 | $140 |
| E.r. Squibb & Sons, L.L.C. | 10 | $134 |
| Baxter Healthcare | 4 | $124 |
| Merck | 7 | $96 |
| AstraZeneca | 6 | $91 |
| Abiomed | 2 | $77 |
| Scpharmaceuticals Inc. | 2 | $59 |
| Bridgebio Pharma, Inc. | 4 | $59 |
| Novo Nordisk | 3 | $53 |
| Amgen | 3 | $42 |
| Medicomp Inc | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Chiesi USA, Inc. | 1 | $26 |
| Medtronic | 1 | $16 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
How this compares
$2,992 in reported general payments places this provider in the 65th percentile of 31 cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 13 | $285,701 |
| XareltoRivaroxaban | 204 | $267,540 |
| EliquisApixaban | 151 | $184,048 |
| JardianceEmpagliflozin | 76 | $79,521 |
| EntrestoSacubitril/Valsartan | 57 | $61,563 |
| MultaqDronedarone Hcl | 21 | $35,811 |
| Repatha SureclickEvolocumab | 15 | $11,111 |
| Metoprolol Succinate | 441 | $6,723 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 15 | $5,703 |
| Nifedipine ErNifedipine | 126 | $4,183 |
| Atorvastatin Calcium | 282 | $3,806 |
| Amlodipine Besylate | 433 | $3,640 |
| Diltiazem 24hr Er (La)Diltiazem Hcl | 20 | $3,630 |
| Losartan Potassium | 230 | $2,544 |
| Valsartan | 38 | $1,698 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerVyndamax, Eliquis | $309 | $469,749164 claims |
| Johnson & JohnsonXarelto | $686 | $267,540204 claims |
| Boehringer IngelheimJardiance | $15 | $79,52176 claims |
| NovartisEntresto | $193 | $61,56357 claims |
| Sanofi-aventis U.S. LLCMultaq | $27 | $35,81121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 31 cardiology providers in New Jersey.
Other cardiology in Brick
- Vasant Paul KateBrick$7K
- Michael SchwarzRutherford$40K
- Beverly DemchukOcean$12K
- Lei XuBrown Hills$10K
- Sarika SharmaRochelle Park$9K
- Pragnesh GadhviUnion City$7K
- Ebrahim IssaTeaneck$5K
- Ricardo CalvoEdison$5K
- Marc ColmerNeptune$5K
- Ian MolkEdison$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.